NEUROPACE
NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers a responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator. NeuroPace was incorporated in 1997 and is based in Mountain View, California.
NEUROPACE
Industry:
Health Care Manufacturing Medical Device Neuroscience
Founded:
1997-01-01
Address:
Mountain View, California, United States
Country:
United States
Website Url:
http://www.neuropace.com
Total Employee:
101+
Status:
Active
Contact:
6502372701
Email Addresses:
[email protected]
Total Funding:
247.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Kerecis
Kerecis develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin.
MIVI Neuroscience
MIVI Neuroscience focuses on developing and commercializing clinical solutions for neurointerventional procedures.
Novoste Puerto Rico
Novoste Puerto Rico develops and markets outpatient angiographic catheters.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Silk Road Medical
Silk Road Medical provides research and development services of medical devices for neurovascular diseases.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
ViewRay
ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - NeuroPace
KCK
KCK investment in Venture Round - NeuroPace
Soleus Capital
Soleus Capital investment in Venture Round - NeuroPace
OrbiMed
OrbiMed investment in Venture Round - NeuroPace
Accelmed
Accelmed investment in Venture Round - NeuroPace
Revelation Partners
Revelation Partners investment in Venture Round - NeuroPace
OrbiMed
OrbiMed investment in Venture Round - NeuroPace
KCK
KCK investment in Venture Round - NeuroPace
MedVenture Associates
MedVenture Associates investment in Venture Round - NeuroPace
Kleiner Perkins
Kleiner Perkins investment in Venture Round - NeuroPace
Official Site Inspections
http://www.neuropace.com Semrush global rank: 3.05 M Semrush visits lastest month: 5.3 K
- Host name: ec2-35-82-192-67.us-west-2.compute.amazonaws.com
- IP address: 35.82.192.67
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "NeuroPace"
Neuropace
Neuropace provides innovative epilepsy treatment solutions and personalized care for patients with focal epilepsy.See details»
NeuroPace - Crunchbase Company Profile & Funding
Organization. NeuroPace . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... NeuroPace was …See details»
NeuroPace, Inc. (NPCE) Company Profile & Facts - Yahoo Finance
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, …See details»
NeuroPace, Inc. Company Profile | Mountain View, CA
Find company research, competitor information, contact details & financial data for NeuroPace, Inc. of Mountain View, CA. Get the latest business insights from Dun & Bradstreet.See details»
NeuroPace Company Profile | Management and Employees List
NeuroPace Profile and History. Founded in 1997 and headquartered in Mountain View, California, NeuroPace designs develops, manufactures, and markets implantable devices for the …See details»
About NeuroPace | Watch the NeuroPace Story
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and …See details»
NeuroPace - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 21, 2025 NeuroPace is a public company based in Mountain View (United States), founded in 1997.It operates as an Implant for treating epilepsy.NeuroPace has raised $264M in funding …See details»
NeuroPace - Funding, Financials, Valuation & Investors - Crunchbase
NeuroPace is registered under the ticker NASDAQ:NPCE . Their stock opened with $17.00 in its Apr 21, 2021 IPO. NeuroPace is funded by 17 investors. National Institutes of Health and KCK …See details»
NeuroPace Announces Refocusing of Product Portfolio
3 days ago MOUNTAIN VIEW, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living …See details»
NeuroPace, Inc. (NPCE): history, ownership, mission, how it works ...
[relinking] Home History Owners Mission How It Works How It Makes Money NeuroPace, Inc. (NPCE) Information A Brief History of NeuroPace, Inc. (NPCE) Company Overview …See details»
NeuroPace - businessabc.net
Feb 25, 2025 Neuropace is a medical technology company that develops and supplies therapies for patients with neurological disorders. The company was founded in 2003 by a group of …See details»
NeuroPace 2025 Company Profile: Stock Performance & Earnings
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating …See details»
NeuroPace - Contacts, Employees, Board Members, Advisors
Organization. NeuroPace . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 14. Number of Board …See details»
NeuroPace Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 NeuroPace has 5 employees at their 1 location and $79.91 m in annual revenue in FY 2024. See insights on NeuroPace including office locations, competitors, revenue, …See details»
Who Owns NeuroPace – CanvasBusinessModel.com
Dec 19, 2024 As a major shareholder, Fischer is deeply invested in the company's success and is committed to driving innovation and growth within the organization. Another important …See details»
NeuroPace Announces Upcoming Oral Presentation of Data from …
For more information on NeuroPace and the RNS System, join us at booth #1642 at the 2025 AAN Annual Meeting or visit https://www.neuropace.com. About NeuroPace, Inc. Based in …See details»
FDA Approves Responsive Neurostimulation Therapy - Epilepsy …
November 13, 2014, MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for …See details»
Neurostimulation system maker NeuroPace files to go public
Mar 25, 2021 NeuroPace, maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, filed SEC documents yesterday outlining plans to raise as …See details»
NeuroPace Company Overview, Contact Details & Competitors
NeuroPace to Present at the Leerink Partners Global Healthcare Conference. MOUNTAIN VIEW, Calif. , March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical …See details»
NeuroPace Announces Refocusing of Product Portfolio
3 days ago NeuroPace may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these …See details»